Dabur Pharma to supply anti-cancer drug to Thailand
Dabur Pharma has entered into an agreement with Government Pharmaceutical Organization of Thailand for the generic of one of its key anti-cancer products.
By INDIATIMES NEWS NETWORK |
MUMBAI: Dabur Pharma has entered into an agreement with Government Pharmaceutical Organization of Thailand for the generic of one of its key anti-cancer products.
"Dabur Pharma is committed to providing high quality anticancer products at cost effective prices. The agreement with GPO has been signed for generic Docetaxel Injection at a very special price. GPO will be importing the product in Thailand and then making it available to needy patients. The Company salutes this humanitarian initiative of the Royal Thai Government and is not looking for economic gains on this deal," said Ajay Kumar Vij, CEO Dabur Pharma.
At 3:11 pm, Dabur Pharma shares were up 1.16 per cent at Rs 65.50 on BSE.
"Dabur Pharma is committed to providing high quality anticancer products at cost effective prices. The agreement with GPO has been signed for generic Docetaxel Injection at a very special price. GPO will be importing the product in Thailand and then making it available to needy patients. The Company salutes this humanitarian initiative of the Royal Thai Government and is not looking for economic gains on this deal," said Ajay Kumar Vij, CEO Dabur Pharma.
At 3:11 pm, Dabur Pharma shares were up 1.16 per cent at Rs 65.50 on BSE.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
